
Current Price | $10.56 | Mkt Cap | $823.3M |
---|---|---|---|
Open | $10.52 | P/E Ratio | 0.00 |
Prev. Close | $10.56 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $10.41 - $10.69 | Volume | 615,844 |
52-Wk Range | $7.13 - $15.24 | Avg. Daily Vol. | 2,974,930 |
Current Price | $10.56 | Mkt Cap | $823.3M |
---|---|---|---|
Open | $10.52 | P/E Ratio | 0.00 |
Prev. Close | $10.56 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $10.41 - $10.69 | Volume | 615,844 |
52-Wk Range | $7.13 - $15.24 | Avg. Daily Vol. | 2,974,930 |
The best Bull and Bear pitches based on recency and number of recommendations.
Speculative Pick (2% max allocation would be wise); Sharing my number one stock pick once again; Where many others have failed and gone home, Anavex continues to march towards the first effective treatment for dementia in history; Stock recently fell… More
Been about 4 years since Anavex raised a heap of money after posting "successful" midstage data. How's that phase 3 Alzheimer's study with 2-73 coming along?
Read the most recent pitches from players about AVXL.
Recs
Speculative Pick (2% max allocation would be wise); Sharing my number one stock pick once again; Where many others have failed and gone home, Anavex continues to march towards the first effective treatment for dementia in history; Stock recently fell after they reported positive Phase I results for another candidate in their pipeline (3-71); Investors are too quick to fold their hands; They forget that she is close to completing Phase III testing for her flagship candidate 2-73; 100% of trial study patients have voluntarily signed up for continued treatment under extended long term study protocols since Phase I; Study goals exceed required FDA data points; They’ve also received positive feedback from preliminary FDA reviews with zero change recommendations offered; I predict full FDA approval before year's end; Stock likely to move long before then regardless of what the general market is doing
Recs
Shrinking deficit and improving technicals.
Recs
Been about 4 years since Anavex raised a heap of money after posting "successful" midstage data. How's that phase 3 Alzheimer's study with 2-73 coming along?
Find the members with the highest scoring picks in AVXL.
Under5 (65.88) Score: +302.64
The Score Leader is the player with the highest score across all their picks in AVXL.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Under5 | 65.88 |
|
![]() |
5Y | $2.13 | +398.59% | +50.49% | +348.10 | 0 Comment | |
DorminABC | 99.74 | 3/17/2011 |
![]() |
NS | $15.28 | -30.50% | +218.33% | +248.83 | 0 Comment | |
conliskjr | < 20 |
|
![]() |
3Y | $2.79 | +280.65% | +95.28% | +185.37 | 0 Comment | |
SunnySky123 | 29.11 | 6/15/2020 |
![]() |
1Y | $3.74 | +183.96% | +35.51% | +148.44 | 0 Comment | |
ttkam20 | < 20 | 8/10/2020 |
![]() |
5Y | $4.19 | +153.46% | +21.58% | +131.88 | 0 Comment | |
portefeuille | 98.02 | 9/22/2016 |
![]() |
5Y | $3.35 | +217.01% | +87.75% | +129.26 | 0 Comment | |
whatisthepoint | 95.31 | 10/12/2015 |
![]() |
5Y | $9.52 | +11.55% | +102.64% | +91.08 | 0 Comment | |
dj8519 | 20.64 | 10/26/2020 |
![]() |
5Y | $5.37 | +97.77% | +19.07% | +78.69 | 0 Comment | |
Theige | 29.10 | 10/12/2015 |
![]() |
5Y | $8.30 | +27.95% | +102.25% | +74.29 | 0 Comment | |
OklaBoston | 48.79 |
|
![]() |
3Y | $5.70 | +86.32% | +20.24% | +66.07 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.